Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally. The company processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. It provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. The company also offers solutions that enable sharing of genetic information consisting of Invitae Family History Tool, an online portal and mobile application that communicates sensitive patient data. In addition, it provides gene sequencing and deletion/duplication analysis; and free re-requisition of additional data within the same indication when ordered, as well as invests in informatics solutions and infrastructure that enable sharing of genetic information to enhance healthcare and clinical outcomes. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
http://www.priceseries.com/trade/NVTA-Invitae-Corporation-stock-gains-38-percent-a-Trade-Record-by-priceSeries-2019020820190306.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments